These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 27003573)

  • 21. Edwards Sapien XT valve placement as treatment option for aortic regurgitation after transfemoral CoreValve implantation: a multicenter experience.
    Diemert P; Lange P; Greif M; Seiffert M; Conradi L; Massberg S; Blankenberg S; Reichenspurner H; Hagl C; Schmitz C; Schröfel H; Treede H; Schymik G; Kupatt C
    Clin Res Cardiol; 2014 Mar; 103(3):183-90. PubMed ID: 24249313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transfemoral aortic valve implantation of Edwards SAPIEN 3 without predilatation.
    Kim WK; Praz F; Blumenstein J; Liebetrau C; Gaede L; Van Linden A; Hamm C; Walther T; Windecker S; Möllmann H
    Catheter Cardiovasc Interv; 2017 Jan; 89(1):E38-E43. PubMed ID: 26945934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. First-in-man transfemoral transcatheter aortic valve replacement with the 29 mm Edwards SAPIEN XT valve.
    Freeman M; Rodés-Cabau J; Urena M; DeLarochelliere R; Dumont E; Masson JB; Willson AB; Binder RK; Toggweiler S; Leipsic J; Wood DA; Webb JG
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):664-70. PubMed ID: 22744829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct transfemoral transcatheter aortic valve implantation without balloon pre-dilatation using the Edwards Sapien XT valve.
    Bandali A; Parry-Williams G; Kassam A; Palmer S; Williams PD; de Belder MA; Owens A; Goodwin A; Muir DF
    Catheter Cardiovasc Interv; 2016 Nov; 88(6):978-985. PubMed ID: 27189391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of transcatheter aortic valve implantation with the newest-generation Sapien 3 vs. Direct Flow Medical valve in a single center cohort.
    Schulz E; Jabs A; Tamm A; Herz P; Schulz A; Gori T; von Bardeleben S; Kasper-König W; Hink U; Vahl CF; Münzel T
    Int J Cardiol; 2017 Apr; 232():186-191. PubMed ID: 28089455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcarotid aortic valve-in-valve implantation for degenerated stentless aortic root conduits with severe regurgitation: a case series.
    Huber C; Praz F; O'Sullivan CJ; Langhammer B; Gloekler S; Stortecky S; von Allmen RS; Meier B; Carrel T; Englberger L; Windecker S; Wenaweser P
    Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):694-700. PubMed ID: 25776924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes of three different new generation transcatheter aortic valve prostheses.
    Costa G; Buccheri S; Barbanti M; Picci A; Todaro D; Di Simone E; La Spina K; D'Arrigo P; Criscione E; Nastasi M; Sgroi C; Tamburino C
    Catheter Cardiovasc Interv; 2020 Feb; 95(3):398-407. PubMed ID: 31609073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Standardized methodology for transfemoral transcatheter aortic valve replacement with the Edwards Sapien XT valve under fluoroscopy guidance.
    Kasel AM; Shivaraju A; Schneider S; Krapf S; Oertel F; Burgdorf C; Ott I; Sumer C; Kastrati A; von Scheidt W; Thilo C
    J Invasive Cardiol; 2014 Sep; 26(9):451-61. PubMed ID: 25198489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of multislice computed tomography findings between bicuspid and tricuspid aortic valves before and after transcatheter aortic valve implantation.
    Watanabe Y; Chevalier B; Hayashida K; Leong T; Bouvier E; Arai T; Farge A; Hovasse T; Garot P; Cormier B; Morice MC; Lefèvre T
    Catheter Cardiovasc Interv; 2015 Aug; 86(2):323-30. PubMed ID: 25594190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcatheter aortic valve implantation in patients with bicuspid aortic valve stenosis.
    Wijesinghe N; Ye J; Rodés-Cabau J; Cheung A; Velianou JL; Natarajan MK; Dumont E; Nietlispach F; Gurvitch R; Wood DA; Tay E; Webb JG
    JACC Cardiovasc Interv; 2010 Nov; 3(11):1122-5. PubMed ID: 21087746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness of the Edwards SAPIEN transcatheter heart valve compared with standard management and surgical aortic valve replacement in patients with severe symptomatic aortic stenosis: a Canadian perspective.
    Doble B; Blackhouse G; Goeree R; Xie F
    J Thorac Cardiovasc Surg; 2013 Jul; 146(1):52-60.e3. PubMed ID: 22795437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transaortic transcatheter aortic valve implantation using SAPIEN XT or SAPIEN 3 valves in the ROUTE registry.
    Romano M; Frank D; Cocchieri R; Jagielak D; Bonaros N; Aiello M; Lapeze J; Laine M; Chocron S; Muir D; Eichinger W; Thielmann M; Labrousse L; Arne Rein K; Verhoye JP; Gerosa G; Baumbach H; Deutsch C; Bramlage P; Thoenes M; Bapat V
    Interact Cardiovasc Thorac Surg; 2017 Nov; 25(5):757-764. PubMed ID: 28582580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcatheter aortic valve implantation with a Sapien 3 Commander 20 mm valves in patients with degenerated 19 mm bioprosthetic aortic valve.
    Loyalka P; Nascimbene A; Schechter M; Petrovic M; Sundara Raman A; Gregoric ID; Kar B
    Catheter Cardiovasc Interv; 2017 Jun; 89(7):1280-1285. PubMed ID: 27696659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transfemoral aortic valve implantation with new-generation devices: the repositionable Lotus vs. the balloon-expandable Edwards Sapien 3 valve.
    Nai Fovino L; Badawy MRA; Fraccaro C; D'Onofrio A; Purita PAM; Frigo AC; Tellaroli P; Mauro A; Tusa M; Napodano M; Gerosa G; Iliceto S; Bedogni F; AbdelRheim AER; Tarantini G
    J Cardiovasc Med (Hagerstown); 2018 Nov; 19(11):655-663. PubMed ID: 30299408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes of Redo Transcatheter Aortic Valve Replacement for the Treatment of Postprocedural and Late Occurrence of Paravalvular Regurgitation and Transcatheter Valve Failure.
    Barbanti M; Webb JG; Tamburino C; Van Mieghem NM; Makkar RR; Piazza N; Latib A; Sinning JM; Won-Keun K; Bleiziffer S; Bedogni F; Kapadia S; Tchetche D; Rodés-Cabau J; Fiorina C; Nombela-Franco L; De Marco F; de Jaegere PP; Chakravarty T; Vaquerizo B; Colombo A; Svensson L; Lange R; Nickenig G; Möllmann H; Walther T; Della Rosa F; Elhmidi Y; Dvir D; Brambilla N; Immè S; Sgroi C; Gulino S; Todaro D; Pilato G; Petronio AS; Tamburino C
    Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27578840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Device landing zone calcification and its impact on residual regurgitation after transcatheter aortic valve implantation with different devices.
    Seiffert M; Fujita B; Avanesov M; Lunau C; Schön G; Conradi L; Prashovikj E; Scholtz S; Börgermann J; Scholtz W; Schäfer U; Lund G; Ensminger S; Treede H
    Eur Heart J Cardiovasc Imaging; 2016 May; 17(5):576-84. PubMed ID: 26160399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet activation is less enhanced in the new balloon expandable Edwards Sapien 3 valve compared to its predecessor model (Edwards Sapien XT).
    Fateh-Moghadam S; Voesch S; Htun P; Jorbenadze R; Geisler T; Gawaz M; Bocksch W
    Thromb Haemost; 2016 Jan; 115(1):109-16. PubMed ID: 26311528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Percutaneous transcatheter aortic valve implantation for degenerated surgical bioprostheses: the first case series in Asia with one-year follow-up.
    Chiam PT; Ewe SH; Soon JL; Ho KW; Sin YK; Tan SY; Lim ST; Koh TH; Chua YL
    Singapore Med J; 2016 Jul; 57(7):401-5. PubMed ID: 27193081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement: insights from the PARTNER I Trial (Placement of Aortic Transcatheter Valve).
    Généreux P; Cohen DJ; Williams MR; Mack M; Kodali SK; Svensson LG; Kirtane AJ; Xu K; McAndrew TC; Makkar R; Smith CR; Leon MB
    J Am Coll Cardiol; 2014 Mar; 63(11):1100-9. PubMed ID: 24291283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial.
    Abdel-Wahab M; Mehilli J; Frerker C; Neumann FJ; Kurz T; Tölg R; Zachow D; Guerra E; Massberg S; Schäfer U; El-Mawardy M; Richardt G;
    JAMA; 2014 Apr; 311(15):1503-14. PubMed ID: 24682026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.